Upgrade to SI Premium - Free Trial

Summit Therapeutics plc (SMMT) PT Lowered to $38 at Guggenheim

July 24, 2026 6:59 AM
(Updated - July 24, 2026 7:51 AM EDT)

Guggenheim analyst Brad Canino lowered the price target on Summit Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change